Journal of Gastrointestinal Infections

Register      Login

VOLUME 9 , ISSUE 1 ( January-December, 2019 ) > List of Articles

Research News Scan

Cephamycins: Treatment Option for Recurrent Clostridioides difficile Infection

Anshul Sood

Citation Information : Sood A. Cephamycins: Treatment Option for Recurrent Clostridioides difficile Infection. J Gastrointest Infect 2019; 9 (1):57-58.

DOI: 10.5005/jp-journals-10068-3029

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Bartlett JG, Moon N, Chang TW, et al. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978;75(5):778–782. DOI: 10.1016/0016-5085(78)90457-2.
  2. Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterol Rep 2018;6(1):21–28. DOI: 10.1093/gastro/gox041.
  3. Srikhanta YN, Hutton ML, Awad MM, et al. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection. Nat Microbiol 2019;4(12):2237–2245. DOI: 10.1038/s41564-019-0519-1.
  4. Lam SW, Neuner EA, Fraser TG, et al. Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting. Infect Control Hosp Epidemiol 2018;39(8):924–930. DOI: 10.1017/ice.2018.139.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.